Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 5,545,654 shares were repurchased during the week of 11 November 2024 up to and including 15 November 2024. The shares were repurchased at an average price of €14.88 or a total amount of €82,507,552.62. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the sha...
NEW YORK--(BUSINESS WIRE)-- , une marque de Dassault Systèmes et leader des solutions d’essais cliniques pour l’industrie des sciences de la vie, a été désignée comme leader dans la première évaluation PEAK Matrix ® des systèmes de gestion des essais cliniques réalisée par Everest Group en 2024. Ce rapport analyse 13 fournisseurs sur la base de l’impact de leurs produits sur le marché ainsi que de leur capacité à offrir des solutions performantes et de qualité. se distingue dans l’industrie en fournissant des données patient transparentes et en temps réel, révolutionnant ainsi le suivi des ...
>Ramp-up in the expansion of Medidata’s solutions portfolio - This week Medidata is holding its annual commercial conference, Medidata Next in New York, with the inaugural keynote speech taking place yesterday (main speakers: CEO of Medidata Anthony Costello, appointed in March, the CTO of Medidata, as well as Bernard Charlès, Executive Chairman and Tarek Sherif, the co-founder of Medidata and now chairman of the Lifescience vertical). The company then organised a ser...
>Accélération de l’expansion du portefeuille de solutions de Medidata - Medidata tient cette semaine sa conférence commerciale annuelle, Medidata Next à New York, avec une keynote inaugurale tenue hier (principaux speakers : le CEO de Medidata Anthony Costello, nommé en mars dernier, le CTO de Medidata, ainsi que Bernard Charlès, Executive Chairman et Tarek Sherif co-fondateur de Medidata, désormais Chairman du vertical Lifescience). La société a ensuite organisé une ...
VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)-- (Euronext Paris: FR0014003TT8, DSY.PA) today announced that has chosen to deploy Dassault Systèmes’ 3DEXPERIENCE platform within its engineering processes for vehicle development. This press release features multimedia. View the full release here: Copyright © Volvo Car Corporation With an automotive industry constantly evolving toward electric, connected and autonomous mobility, companies must be able to accelerate the launch of advanced solutions. The 3DEXPERIENCE platform helps automotive manufacturers streamline enterprise-wide collaboration...
NEW YORK--(BUSINESS WIRE)-- , a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a leader in Everest Group's first-ever Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment 2024. The report assessed 13 providers based on the market impact of their products and their ability to deliver successful, high-quality offerings. leads the industry by providing seamless, real-time patient data outputs that transform enrollment tracking and enable faster, data-driven decisions. Offering instant...
NEW YORK--(BUSINESS WIRE)-- , a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off , its premier life sciences conference. Uniting more than 1,000 healthcare customers and partners, the event will showcase AI-powered innovations that accelerate clinical trials, streamline data management, and enhance decision-making for life-saving therapies. At the event, Medidata will unveil three experiences centered on the full ecosystem of clinical trials—data management, patient engagement, and study coordination—providing tools that streamline ...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 7,704,055 shares were repurchased during the week of 4 November 2024 up to and including 8 November 2024. The shares were repurchased at an average price of €15.35 or a total amount of €118,240,205.76. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see . In line with the purpose of the programme to reduce the share capital of ING, t...
>Solid Q3 driven by resilient Europe and solid Brazil - ArcelorMittal released solid Q3 results with EBITDA of $ 1.58bn, down 15% QoQ and 26% y-o-y but 6% above consensus and 7% above ODDO BHF. The beat was mostly driven by resilient volumes and better costs (including raw mats) that offset lower shipments. By division, Brazil at $ 0.5bn was the sole higher vs Q2, thanks to better seasonality and good cost control. Despite a weaker environment, Europe at $0.4bn also ...
>Solid Q3 driven by resilient Europe and solid Brazil - ArcelorMittal released solid Q3 results with EBITDA of $ 1.58bn, down 15% QoQ and 26% y-o-y but 6% above consensus and 7% above ODDO BHF. The beat was mostly driven by resilient volumes and better costs (including raw mats) that offset lower shipments. By division, Brazil at $ 0.5bn was the sole higher vs Q2, thanks to better seasonality and good cost control. Despite a weaker environment, Europe at $0.4bn also ...
Aalberts: Building already bottoming, industry tough. Air France-KLM: Nobody helps. Alfen: Covenant agreement, hikes output Smart Grid. AMG: Sweet for 2024F, sour for 2025F. ArcelorMittal: 3Q24 EBITDA beats by 6%, FCF solid. BAM: 3Q beats, on its way to reach FY guidance. CMB.TECH: 3Q and FY24 reasonable but then more challenges. D'Ieteren: EGM and dividend dates announced; Belron US peer Boyd disappointing 3Q24. GBL: Double-digit TSR expected over 2024-27F. KBC: 3Q better acro...
ArcelorMittal S.A.: ArcelorMittal reports third quarter 2024 results Luxembourg, November 7, 2024 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for the three-month and nine-month periods ended September 30, 2024. 3Q 2024 key highlights: Safety focus: The Company-wide audit of safety by dss+ is now complete. It has provided the Group with a clear set of 6 recommendations which the Company is committed to implement....
1M Performance - Absolute: During Oct'24 (1M period), the KBCS Holdings Universe posted a return of -2.5% which was mainly driven by single-asset holdings (-2.8%) while multi-asset holdings posted a slightly less negative return of -2.3%. The 3 top performers during the period were Financière de Tubize (+6.7%), D'Ieteren Group (+4.5%), and Solvac (+2.8%) while the 3 worst performers were Sofina (-11.4%), Gimv (-9.8%), and Compagnie du Bois Sauvage (-6.3%). YTD Performance - Relative: On a YTD ...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 4,016,274 shares were repurchased during the week of 31 October 2024 up to and including 1 November 2024. In line with the purpose of the programme to reduce the share capital of ING, the ordinary shares were repurchased at an average price of €15.64 for a total consideration of €62,798,086.93. To date approximately 3.14% of the maximum total value of the share buyback programme has been completed. F...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.